Hall Laurie J Trustee Seagen Inc. Transaction History

Hall Laurie J Trustee

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 11, 2023	SELL	$117.37 - $139.17 $4,694 - $5,566	-40 Reduced 38.1%	65 $8,000
Q3 2022 Oct 11, 2022	SELL	$135.27 - $180.11 $10,145 - $13,508	-75 Reduced 41.67%	105 $14,000
Q3 2021 Oct 04, 2021	SELL	$142.45 - $169.82 $15,669 - $18,680	-110 Reduced 37.93%	180 $31,000
Q4 2020 Jan 25, 2021	BUY	$164.63 - $211.93 $47,742 - $61,459	290 New	290 $51,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Hall Laurie J Trustee, based on Form 13F filings with the SEC.

Stay updated on Hall Laurie J Trustee with notifications on news.